tiprankstipranks
Trending News
More News >
Corcept Therapeutics Inc. (CORT)
NASDAQ:CORT

Corcept Therapeutics (CORT) Revenue

Compare
993 Followers

Corcept Therapeutics Revenue

Corcept Therapeutics had a revenue of 157.21M in the quarter ending Mar 31, 2025, with -13.57%. This bring the company's revenue in the last twelve months to 685.45M, Decreased 1.54%. In the fiscal year ending Dec 31, 2024, Corcept Therapeutics had annual revenue of 675.04M with 39.94% growth.
Revenue (ttm)
685.45M
Revenue Growth
30.93%
P/S Ratio
11.14
Revenue/Employee
$1,350,080
Employees
500
Market Cap
$7.52B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
675.04M192.66M+39.94%
Dec 31, 2023
482.38M80.52M+20.04%
Dec 31, 2022
401.86M35.88M+9.80%
Dec 31, 2021
365.98M12.10M+3.42%
Dec 31, 2020
353.87M47.39M+15.46%
Dec 31, 2019
306.49M55.24M+21.99%
Dec 31, 2018
251.25M92.05M+57.82%
Dec 31, 2017
159.20M77.88M+95.77%
Dec 31, 2016
81.32M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis